Gilead Sciences Inc
F:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
F:GIS
|
US |
|
Brown & Brown Inc
NYSE:BRO
|
US |
|
C
|
Coca Cola HBC AG
OTC:CCHBF
|
CH |
|
PayPal Holdings Inc
MIL:1PYPL
|
US |
|
Kanabo Group PLC
F:3WD
|
UK |
|
V
|
Veeco Instruments Inc
XMUN:VEO
|
US |
|
M
|
Marriott International Inc
F:MAQ
|
US |
|
Midland Exploration Inc
OTC:MIDLF
|
CA |
|
B
|
Best Buy Co Inc
XMUN:BUY
|
US |
|
Pexip Holding ASA
OTC:PXPHF
|
NO |
|
AIA Group Ltd
F:7A2S
|
HK |
|
TotalEnergies SE
LSE:TTE
|
FR |
|
U
|
UDR Inc
F:UF0
|
US |
|
F
|
Freeport-McMoRan Inc
XBER:FPMB
|
US |
|
D
|
Duerr AG
XHAM:DUE
|
DE |
|
Delta Dunia Makmur Tbk PT
IDX:DOID
|
ID |
|
N
|
Nikon Corp
OTC:NINOY
|
JP |
|
D
|
Dakota Gold Corp
F:RR6
|
US |
|
M
|
Marathon Oil Corp
F:USS
|
US |
|
L
|
Lamar Advertising Co
XBER:6LA
|
US |
Bankruptcy Probability
Gilead Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gilead Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
88.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
28.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gilead Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gilead Sciences Inc has total debt of 22.1B USD. This includes both short-term (0 USD) and long-term (22.1B USD) debt.
You can find a full breakdown on its Balance Sheet.
